Science & Pipeline
Pipeline.
Redefining the future of combination therapy
Duo Oncology is developing tumor-activated conjugates that integrate established and emerging cancer medicines into stronger, simpler and safer combination therapies.
Program
Disease Area
Discovery
Pre-Clinical
Phase 1
Pancreatic + 2nd or 3rd Lung & Breast
DUO-209
Leukemia + Lymphoma + MDS
DUO-307
Bladder + Head & Neck + 1st Lung
Platform Products
Partnered
Program
DUO-207
Clinical
Disease Area: Pancreatic + 2nd or 3rd Line Lung & Breast
DUO-307
Pre-Clinical
Disease Area: Bladder + Head & Neck + 1st Line Lung
DUO-209
Pre-Clinical
Disease Area: Leukemia + Lymphoma + Myeloma
Platform Products
Discovery
Disease Area: Partnered Programs